DEP-Dots for 3D cell culture: low-cost, high-repeatability, effective 3D cell culture in multiple gel systems
It is known that cells grown in 3D are more tolerant to drug treatment than those grown in dispersion, but the mechanism for this is still not clear; cells grown in 3D have opportunities to develop inter-cell communication, but are also closely packed which may impede diffusion.
In this study we examine methods for dielectrophoresis-based cell aggregation of both suspension and adherent cell lines, and compare the effect of various drugs on cells grown in 3D and 2D. Comparing viability of pharmacological interventions on 3D cell clusters against both suspension cells and adherent cells grown in monolayer, as well as against a unicellular organism with no propensity for intracellular communication, we suggest that 3D aggregates of adherent cells, compared to suspension cells, show a substantially different drug response to cells grown in monolayer, which increases as the IC50 is approached.
Further, a mathematical model of the system for each agent demonstrates that changes to drug response are due to inherent changes in the system of adherent cells from the 2D to 3D state. Finally, differences in the electrophysiological membrane properties of the adherent cell type suggest this parameter plays an important role in the differences found in the 3D drug response.
rHu MIP-3-beta |
|||
AK8232-0100 | Akron Biotech | 100µg | Ask for price |
rHu MIP-3-beta |
|||
AK8232-1000 | Akron Biotech | 1mg | Ask for price |
rHu MIP-1-beta |
|||
AK8264-0002 | Akron Biotech | 2µg | Ask for price |
rHu MIP-1-beta |
|||
AK8264-0010 | Akron Biotech | 10µg | Ask for price |
rHu MIP-1-beta |
|||
AK8264-0100 | Akron Biotech | 100µg | Ask for price |
rHu MIP-1-beta |
|||
AK8264-1000 | Akron Biotech | 1mg | Ask for price |
rHu MIP-1-alpha |
|||
AK8250-0005 | Akron Biotech | 5µg | Ask for price |
rHu MIP-1-alpha |
|||
AK8250-0020 | Akron Biotech | 20µg | Ask for price |
rHu MIP-1-alpha |
|||
AK8250-0100 | Akron Biotech | 100µg | Ask for price |
rHu MIP-1-alpha |
|||
AK8250-1000 | Akron Biotech | 1mg | Ask for price |
rHu MIP-3-alpha |
|||
AK8271-0005 | Akron Biotech | 5µg | Ask for price |
rHu MIP-3-alpha |
|||
AK8271-0020 | Akron Biotech | 20µg | Ask for price |
rHu MIP-3-alpha |
|||
AK8271-0100 | Akron Biotech | 100µg | Ask for price |
rHu MIP-3-alpha |
|||
AK8271-1000 | Akron Biotech | 1mg | Ask for price |
Recombinant Human MIP-3/CCL23 (rHu MIP-3/CCL23) |
|||
JOT-PR1097 | Jotbody | 5µg | EUR 205 |
Description: Fully biologically active when compared to standard. Determined by its ability to chemoattract human T cell population using a concentration range of 10.0 -50.0 ng/ml, corresponding to a Specific Activity of >2 x 104 IU/mg. |
Recombinant Human MIP-3/CCL23 (rHu MIP-3/CCL23) |
|||
PR1097 | Bioworld Biotech | 5µg | EUR 158 |
Description: Fully biologically active when compared to standard. Determined by its ability to chemoattract human T cell population using a concentration range of 10.0 -50.0 ng/ml, corresponding to a Specific Activity of >2 x 104 IU/mg. |
Recombinant Human MIP-1 beta (rHu MIP-1 beta /CCL4 |
|||
JOT-PR1095 | Jotbody | 2µg | EUR 205 |
Description: Determined by its ability to chemoattract human blood monocytes using a concentration range of 5.0-20.0 ng/ml, corresponding to a Specific Activity of >5 x 104 IU/mg. |
Recombinant Human MIP-1 beta (rHu MIP-1 beta /CCL4 |
|||
PR1095 | Bioworld Biotech | 2µg | EUR 158 |
Description: Determined by its ability to chemoattract human blood monocytes using a concentration range of 5.0-20.0 ng/ml, corresponding to a Specific Activity of >5 x 104 IU/mg. |
Recombinant Human MIP-1 alpha (CCL3) (rHu MIP-1 alpha (CCL3)) |
|||
JOT-PR1094 | Jotbody | 5µg | EUR 205 |
Description: Determined by its ability to chemoattract human monocytes using a concentration range of 1.0-10.0 ng/ml, corresponding to a Specific Activity of >1 x 105 IU/mg. |
Recombinant Human MIP-1 alpha (CCL3) (rHu MIP-1 alpha (CCL3)) |
|||
PR1094 | Bioworld Biotech | 5µg | EUR 158 |
Description: Determined by its ability to chemoattract human monocytes using a concentration range of 1.0-10.0 ng/ml, corresponding to a Specific Activity of >1 x 105 IU/mg. |
rHu IL-4 |
|||
AK8329-0005 | Akron Biotech | 5µg | Ask for price |
rHu IL-4 |
|||
AK8329-0020 | Akron Biotech | 20µg | Ask for price |
rHu IL-4 |
|||
AK8329-0100 | Akron Biotech | 100µg | Ask for price |
rHu IL-4 |
|||
AK8329-1000 | Akron Biotech | 1mg | Ask for price |
rHu MCP-4 |
|||
AK8332-0005 | Akron Biotech | 5µg | Ask for price |
rHu MCP-4 |
|||
AK8332-0020 | Akron Biotech | 20µg | Ask for price |
rHu MCP-4 |
|||
AK8332-0100 | Akron Biotech | 100µg | Ask for price |
rHu MCP-4 |
|||
AK8332-1000 | Akron Biotech | 1mg | Ask for price |
rHu FGF-4 |
|||
AK9698-0005 | Akron Biotech | 5µg | Ask for price |
rHu FGF-4 |
|||
AK9698-0025 | Akron Biotech | 25µg | Ask for price |
rHu FGF-4 |
|||
AK9698-0100 | Akron Biotech | 100µg | Ask for price |
rHu FGF-4 |
|||
AK9698-1000 | Akron Biotech | 1mg | Ask for price |
Recombinant Human MIP-4 (rHuMIP-4/CCL18) |
|||
JOT-PR1098 | Jotbody | 2µg | EUR 205 |
Description: Fully biologically active when compared to standard. Determined by its ability to chemoattract human T lymphocytes using a concentration range of 1.0 -10.0 ng/ml, corresponding to a Specific Activity of >1 x 105 IU/mg. |
Recombinant Human MIP-4 (rHuMIP-4/CCL18) |
|||
PR1098 | Bioworld Biotech | 2µg | EUR 158 |
Description: Fully biologically active when compared to standard. Determined by its ability to chemoattract human T lymphocytes using a concentration range of 1.0 -10.0 ng/ml, corresponding to a Specific Activity of >1 x 105 IU/mg. |
rHu IL-4 (cGMP) |
|||
AK9839-0000 | Akron Biotech | 1mg | Ask for price |
rHu BMP-4 (CHO) |
|||
AK9996-0005 | Akron Biotech | 5µg | Ask for price |
rHu BMP-4 (CHO) |
|||
AK9996-0020 | Akron Biotech | 20µg | Ask for price |
rHu BMP-4 (CHO) |
|||
AK9996-0100 | Akron Biotech | 100µg | Ask for price |
rHu BMP-4 (CHO) |
|||
AK9996-1000 | Akron Biotech | 1mg | Ask for price |
MIP-4 |
|||
GWB-915E16 | GenWay Biotech | 0.01 mg | Ask for price |
MIP 4 |
|||
chm-322 | ProSpec Tany | 2µg | EUR 60 |
Description: Recombinant Human Macrophage Inflammatory protein-4 (CCL18) |
rHu MIF |
|||
AK8255-0005 | Akron Biotech | 5µg | Ask for price |
rHu MIF |
|||
AK8255-0025 | Akron Biotech | 25µg | Ask for price |
rHu MIF |
|||
AK8255-0100 | Akron Biotech | 100µg | Ask for price |
rHu MIF |
|||
AK8255-1000 | Akron Biotech | 1mg | Ask for price |
rHu EGF |
|||
AK8327-0100 | Akron Biotech | 100µg | Ask for price |
rHu EGF |
|||
AK8327-0500 | Akron Biotech | 500µg | Ask for price |
rHu EGF |
|||
AK8327-1000 | Akron Biotech | 1mg | Ask for price |
rHu OSM |
|||
AK8531-0002 | Akron Biotech | 2µg | Ask for price |
rHu OSM |
|||
AK8531-0010 | Akron Biotech | 10µg | Ask for price |
rHu OSM |
|||
AK8531-0100 | Akron Biotech | 100µg | Ask for price |
rHu OSM |
|||
AK8531-1000 | Akron Biotech | 1mg | Ask for price |
rHu SHH |
|||
AK9088-0005 | Akron Biotech | 5µg | Ask for price |
rHu SHH |
|||
AK9088-0025 | Akron Biotech | 25µg | Ask for price |
rHu SHH |
|||
AK9088-0100 | Akron Biotech | 100µg | Ask for price |
rHu SHH |
|||
AK9088-1000 | Akron Biotech | 1mg | Ask for price |
rHu TPO |
|||
AK9089-0002 | Akron Biotech | 5µg | Ask for price |
rHu TPO |
|||
AK9089-0010 | Akron Biotech | 20µg | Ask for price |
rHu TPO |
|||
AK9089-0100 | Akron Biotech | 100µg | Ask for price |
rHu TPO |
|||
AK9089-1000 | Akron Biotech | 1mg | Ask for price |
rHu PTN |
|||
AK9912-0005 | Akron Biotech | 5µg | Ask for price |
rHu PTN |
|||
AK9912-0020 | Akron Biotech | 20µg | Ask for price |
rHu PTN |
|||
AK9912-0100 | Akron Biotech | 100µg | Ask for price |
rHu PTN |
|||
AK9912-1000 | Akron Biotech | 1mg | Ask for price |
rHu LIF |
|||
AK9977-0005 | Akron Biotech | 5µg | Ask for price |
rHu LIF |
|||
AK9977-0025 | Akron Biotech | 25µg | Ask for price |
rHu LIF |
|||
AK9977-0100 | Akron Biotech | 100µg | Ask for price |
rHu LIF |
|||
AK9977-1000 | Akron Biotech | 1mg | Ask for price |
rHu MIG |
|||
AK9979-0005 | Akron Biotech | 5µg | Ask for price |
rHu MIG |
|||
AK9979-0020 | Akron Biotech | 20µg | Ask for price |
rHu MIG |
|||
AK9979-0100 | Akron Biotech | 100µg | Ask for price |
rHu MIG |
|||
AK9979-1000 | Akron Biotech | 1mg | Ask for price |
rHu aFGF |
|||
AK8230-0010 | Akron Biotech | 10µg | Ask for price |
rHu aFGF |
|||
AK8230-0050 | Akron Biotech | 50µg | Ask for price |
rHu aFGF |
|||
AK8230-0100 | Akron Biotech | 100µg | Ask for price |
rHu aFGF |
|||
AK8230-1000 | Akron Biotech | 1mg | Ask for price |
rHu MCSF |
|||
AK8238-0002 | Akron Biotech | 2µg | Ask for price |
rHu MCSF |
|||
AK8238-0010 | Akron Biotech | 10µg | Ask for price |
rHu MCSF |
|||
AK8238-0100 | Akron Biotech | 100µg | Ask for price |
rHu MCSF |
|||
AK8238-1000 | Akron Biotech | 1mg | Ask for price |
rHu CTGF |
|||
AK8240-0005 | Akron Biotech | 5µg | Ask for price |
rHu CTGF |
|||
AK8240-0020 | Akron Biotech | 20µg | Ask for price |
rHu CTGF |
|||
AK8240-0100 | Akron Biotech | 100µg | Ask for price |
rHu CTGF |
|||
AK8240-1000 | Akron Biotech | 1mg | Ask for price |
rHu BDNF |
|||
AK8286-0002 | Akron Biotech | 2µg | Ask for price |
rHu BDNF |
|||
AK8286-0010 | Akron Biotech | 10µg | Ask for price |
rHu BDNF |
|||
AK8286-0100 | Akron Biotech | 100µg | Ask for price |
rHu BDNF |
|||
AK8286-1000 | Akron Biotech | 1mg | Ask for price |
rHu CNTF |
|||
AK8302-0005 | Akron Biotech | 5µg | Ask for price |
rHu CNTF |
|||
AK8302-0020 | Akron Biotech | 20µg | Ask for price |
rHu CNTF |
|||
AK8302-0100 | Akron Biotech | 100µg | Ask for price |
rHu CNTF |
|||
AK8302-1000 | Akron Biotech | 1mg | Ask for price |
rHu GDNF |
|||
AK8335-0002 | Akron Biotech | 2µg | Ask for price |
rHu GDNF |
|||
AK8335-0010 | Akron Biotech | 10µg | Ask for price |
rHu GDNF |
|||
AK8335-0100 | Akron Biotech | 100µg | Ask for price |
rHu GDNF |
|||
AK8335-1000 | Akron Biotech | 1mg | Ask for price |
rHu BAFF |
|||
AK8540-0005 | Akron Biotech | 5µg | Ask for price |
rHu BAFF |
|||
AK8540-0020 | Akron Biotech | 20µg | Ask for price |
rHu BAFF |
|||
AK8540-0100 | Akron Biotech | 100µg | Ask for price |
Novel humanin analogs confer neuroprotection and myoprotection to neuronal and myoblast cell cultures exposed to ischemia-like and doxorubicin-induced cell death insults
Humanin (HN) is a 24-amino acid mitochondrial-derived peptide, best known for its ability to protect neurons from damage caused by ischemic stroke and neurodegenerative insults and cardiomyocytes from myocardial infarction or doxorubicin (Dox)-induced cardiotoxicity.
This study examines the neuroprotective and myoprotective effects of HN novel synthetic analogs HUJInin and c(d-ser14)HN, prepared by solid-phase peptide synthesis. The cellular models employed were oxygen-glucose-deprivation (OGD) followed by reoxygenation (R)-induced neurotoxicity in PC12 and SH-SY5Y neuronal cell cultures and Dox-induced cardiotoxicity in H9c2 and C2C12 myoblast cell cultures, respectively.
Necrotic and apoptotic cell death was measured by LDH release and caspase-3 activity. Erk 1/2 and AKT phosphorylations were examined by western blotting. Mitochondrial calcium and mitochondrial membrane potential were measured using the fluorescent dye tetramethylrhodamine-methyl ester. It was found that HUJInin and c(d-ser14)HN conferred significant dose-dependent neuroprotection, a phenomenon related to attenuation of OGD insult-induced Erk 1/2 phosphorylation, stimulation of AKT phosphorylation and improvement of mitochondrial functions.
These peptides also conferred myoprotective effect towards (Dox)-induced apo-necrotic cell death insults. HUJInin and c(d-ser14)HN synthetic analogs may provide new lead compounds for the development of a potential candidate drug for stroke treatment and/or DOX-induced cardiotoxicity therapy in cancer patients.
Enhancing the Furosemide Permeability by Papain Minitablets Through a Triple Co-culture In Vitro Intestinal Cell Model
The administration of medicines by the oral route is the most used approach for being very convenient. Although it is the most popular, this route also has absorption, and consequently, bioavailability limitations. In this sense, several pharmacotechnical strategies have been used to improve drug absorption, one of which is the use of permeation promoters.
Papain is a very versatile plant enzyme that can be used as a permeation promoter of various active compounds. This study aimed to evaluate the safety of papain and the formulation of native papain minitablets to promote in vitro permeation of furosemide through an innovative biomimetic triple co-culture model of Caco-2, HT29-MTX, and Raji cells.
Regarding permeation, furosemide and metaprolol concentrations are determined with HPLC; those are used to calculate Papp. Monolayer integrity was evaluated using TEER and Lucifer Yellow. In the presence of papain, TEER decreased two-fold and the Papp of furosemide increased six-fold.
The results suggest that native papain minitablets can be used as therapeutic adjuvants to enhance the permeation of drugs significantly improving bioavailability.
Recombinant CCL19 (MIP-3β) |
|||
MBS197063-002mg | MyBiosource | 0.02mg | EUR 285 |
Recombinant CCL19 (MIP-3β) |
|||
MBS197063-005mg | MyBiosource | 0.05mg | EUR 405 |
Recombinant CCL19 (MIP-3β) |
|||
MBS197063-01mg | MyBiosource | 0.1mg | EUR 605 |
Recombinant CCL19 (MIP-3β) |
|||
MBS197063-1mg | MyBiosource | 1mg | EUR 2540 |
Recombinant Human MIP-3 beta |
|||
MBS7611183-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Human MIP-3 beta |
|||
MBS7611183-02mg | MyBiosource | 0.2mg | EUR 635 |
Recombinant Human MIP-3 beta |
|||
MBS7611183-1mg | MyBiosource | 1mg | EUR 1800 |
Recombinant Human MIP-3 beta |
|||
MBS7611183-5x1mg | MyBiosource | 5x1mg | EUR 6955 |
Recombinant Mouse MIP-3 beta |
|||
MBS7608911-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Mouse MIP-3 beta |
|||
MBS7608911-02mg | MyBiosource | 0.2mg | EUR 635 |
Recombinant Mouse MIP-3 beta |
|||
MBS7608911-1mg | MyBiosource | 1mg | EUR 1800 |
Recombinant Mouse MIP-3 beta |
|||
MBS7608911-5x1mg | MyBiosource | 5x1mg | EUR 6955 |
MIP-3 beta Recombinant Protein |
|||
40-354-0005mg | ProSci | 0.005 mg | EUR 311.1 |
Description: MIP-3 beta is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3 beta is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3 beta is active on murine cells. Recombinant murine MIP-3 beta is a 9.2 kDa protein containing 83 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
MIP-3 beta Recombinant Protein |
|||
40-354-002mg | ProSci | 0.02 mg | EUR 437.1 |
Description: MIP-3 beta is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3 beta is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3 beta is active on murine cells. Recombinant murine MIP-3 beta is a 9.2 kDa protein containing 83 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
MIP-3 beta Recombinant Protein |
|||
40-381-0005mg | ProSci | 0.005 mg | EUR 311.1 |
Description: MIP-3 beta is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3 beta is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3 beta is active on murine cells. Recombinant human MIP-3 beta is an 8.8 kDa protein containing 77 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
MIP-3 beta Recombinant Protein |
|||
40-381-002mg | ProSci | 0.02 mg | EUR 437.1 |
Description: MIP-3 beta is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3 beta is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3 beta is active on murine cells. Recombinant human MIP-3 beta is an 8.8 kDa protein containing 77 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
Human MIP-3 beta ELISA Kit |
|||
GWB-SKR155 | GenWay Biotech | 96 Tests | Ask for price |
Human MIP-3 beta ELISA Kit |
|||
K0332182 | KOMA BIOTECH | 96well | EUR 271 |
RABBIT ANTI HUMAN MIP-3 BETA |
|||
MBS221727-01mg | MyBiosource | 0.1mg | EUR 635 |
RABBIT ANTI HUMAN MIP-3 BETA |
|||
MBS221727-5x01mg | MyBiosource | 5x0.1mg | EUR 2695 |
MIP-3 beta, CCL19, murine (mouse) |
|||
RC335-20 | Bio Basic | 5ug | EUR 121.6 |
Anti-Human MIP-3 beta Antibody |
|||
101-M80 | ReliaTech | 500 µg | EUR 246.75 |
Description: MIP-3β is a CC chemokine, expressed in the thymus, lymph nodes, and in activated bone marrow stromal cells that signals through the CCR7 receptor. MIP-3β is a chemoattractant for T and B lymphocytes, and myeloid progenitor cells. Human MIP-3β is active on murine cells. Recombinant Murine MIP-3β is a 9.2 kDa protein containing 83 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
Anti-Human MIP-3 beta Antibody |
|||
102-P68 | ReliaTech | 100 µg | EUR 245.7 |
Description: MIP-3β is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3β is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3β is active on mouse cells. Recombinant human MIP-3β is an 8.8 kDa protein containing 77 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
MIP-3 beta Recombinant Rabbit mAb |
|||
BS48616 | Bioworld Biotech | 50 ul | EUR 398 |
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt. |
MIP-3 beta Recombinant Rabbit mAb |
|||
BS48624 | Bioworld Biotech | 50 ul | EUR 398 |
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt. |
Recombinant Human MIP-3 beta (CCL19) |
|||
MBS4159807-002mg | MyBiosource | 0.02mg | EUR 345 |
Recombinant Human MIP-3 beta (CCL19) |
|||
MBS4159807-1mg | MyBiosource | 1(mg) | EUR 4600 |
Recombinant Human MIP-3 beta (CCL19) |
|||
MBS4159807-5x1mg | MyBiosource | 5x1mg | EUR 20445 |
Recombinant Human MIP-3 beta (CCL19) |
|||
Z101945 | ABM | 20 µg | EUR 195 |
Description: CCL19 is a chemokine that belongs to the CC family of growth factors and signals through the CCR7 receptor. CCl19 has been shown to be expressed in the thymus, lymph nodes and in activated bone marrow stromal cells. When anti-inflammatory signals are released, expression of CCL19 gets down-regulated – specifically by IL-10. |
Recombinant Human MIP-3 beta (CCL19) |
|||
Z101949 | ABM | 1.0 mg | EUR 3900 |
Description: CCL19 is a chemokine that belongs to the CC family of growth factors and signals through the CCR7 receptor. CCl19 has been shown to be expressed in the thymus, lymph nodes and in activated bone marrow stromal cells. When anti-inflammatory signals are released, expression of CCL19 gets down-regulated – specifically by IL-10. |
Recombinant Murine MIP-3 beta /CCL19 |
|||
MECCP-1901 | Cyagen | 5ug | Ask for price |
Recombinant Human MIP-1 beta (rHu MIP-1 beta /CCL4 |
|||
JOT-PR1095 | Jotbody | 2µg | EUR 205 |
Description: Determined by its ability to chemoattract human blood monocytes using a concentration range of 5.0-20.0 ng/ml, corresponding to a Specific Activity of >5 x 104 IU/mg. |
Recombinant Human MIP-1 beta (rHu MIP-1 beta /CCL4 |
|||
PR1095 | Bioworld Biotech | 2µg | EUR 158 |
Description: Determined by its ability to chemoattract human blood monocytes using a concentration range of 5.0-20.0 ng/ml, corresponding to a Specific Activity of >5 x 104 IU/mg. |
Rat MIP-1 beta |
|||
MBS691673-0005mg | MyBiosource | 0.005mg | EUR 300 |
Rat MIP-1 beta |
|||
MBS691673-002mg | MyBiosource | 0.02mg | EUR 450 |
Rat MIP-1 beta |
|||
MBS691673-5x002mg | MyBiosource | 5x0.02mg | EUR 1725 |
Human CCL19/MIP-3 beta ELISA Kit |
|||
LF-EK50840 | Abfrontier | 1×96T | EUR 777.6 |
Human CCL19/MIP-3 Beta ELISA Kit |
|||
EK5194 | SAB | 96 tests | EUR 599 |
Mouse CCL19/MIP-3 beta ELISA Kit |
|||
EK5195 | SAB | 96 tests | EUR 599 |
CCL19 / MIP-3 beta (Human) ELISA Kit |
|||
EK-045-68 | PHOENIX PEPTIDE | 96 wells | EUR 603.72 |
Mouse MIP-1 beta |
|||
MBS691963-0002mg | MyBiosource | 0.002mg | EUR 300 |
Mouse MIP-1 beta |
|||
MBS691963-001mg | MyBiosource | 0.01mg | EUR 450 |
Mouse MIP-1 beta |
|||
MBS691963-5x001mg | MyBiosource | 5x0.01mg | EUR 1725 |
MIP-1 beta Antibody |
|||
GWB-185AB9 | GenWay Biotech | 0.1 mg | Ask for price |
MIP 1 beta antibody |
|||
20R-1789 | Fitzgerald | 100 ug | EUR 807.6 |
Description: Rabbit polyclonal MIP 1 beta antibody |
MIP 1 beta antibody |
|||
MBS835136-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Anti-Ccl19/MIP-3 beta Picoband Antibody |
|||
MBS1750677-01mg | MyBiosource | 0.1mg | EUR 450 |
Anti-Ccl19/MIP-3 beta Picoband Antibody |
|||
MBS1750677-5x01mg | MyBiosource | 5x0.1mg | EUR 1870 |
Human MIP-3 beta (CCL19) Recombinant Protein |
|||
100-079 | ReliaTech | 20 µg | EUR 196.35 |
Description: MIP-3β is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3β is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3β is active on murine cells. Recombinant human MIP-3β is an 8.8 kDa protein containing 77 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
Human MIP-3 beta (CCL19) Recombinant Protein |
|||
100-079S | ReliaTech | 5 µg | EUR 92.4 |
Description: MIP-3β is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3β is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3β is active on murine cells. Recombinant human MIP-3β is an 8.8 kDa protein containing 77 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
Recombinant Mouse MIP-3 Beta/CCL19 protein |
|||
CD00293-5ug | Jiaxing Korain Biotech Ltd (BT Labs) | 5ug | EUR 176 |
Description: CCL19, also known as EBI1 Ligands chemokine (ELC) and macrophage inflammatory protein-3-beta, is encoded by the CCL19 gene which is located on chromosome 4 in mouse. The protein is expressed at high levels in thymus and lymph nodes, with intermediate levels in trachea and colon and low levels in stomach, lung and some other organs. CCL19 is signal through CCR7 and chemotaxis of T and B lymphocytes and myeloid progenitor cells. |
Mouse MIP-3 beta (CCL19) Recombinant Protein |
|||
M10-079 | ReliaTech | 20 µg | EUR 196.35 |
Description: MIP-3β is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3β is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3β is active on murine cells. Mouse urine MIP-3β is a 9.2 kDa protein containing 83 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
Mouse MIP-3 beta (CCL19) Recombinant Protein |
|||
M10-079S | ReliaTech | 5 µg | EUR 92.4 |
Description: MIP-3β is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3β is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3β is active on murine cells. Mouse urine MIP-3β is a 9.2 kDa protein containing 83 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
Human CCL19/MIP-3 beta Recombinant Protein |
|||
PROTQ99731 | BosterBio | Regular: 20ug | EUR 243 |
Description: Human CCL19/MIP-3 beta Recombinant Protein expressed in E. coli with T7-tag. Sequence domain: 22-98aa. Application(s): SDS-PAGE. Endotoxin: < 1 EU per 1ug of protein (determined by LAL method). |
Recombinant Human MIP-3 Beta (CCL19) Protein |
|||
PROTQ99731-1 | BosterBio | 20ug | EUR 380.4 |
Description: MIP-3β is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3β is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3β is active on murine cells. Recombinant human MIP-3β is an 8.8 kDa protein containing 77 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
Recombinant Human CCL19/MIP-3 beta Protein |
|||
RP01832 | Abclonal | 10μg | EUR 364.88 |
Recombinant Human CCL19/MIP-3 beta Protein |
|||
RP01634 | Abclonal | 100μg | EUR 38.97 |
Recombinant Murine MIP-3 Beta (CCL19) Protein |
|||
PROTO70460-2 | BosterBio | 20ug | EUR 380.4 |
Description: MIP-3β is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3β is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3β is active on murine cells. Recombinant murine MIP-3β is a 9.2 kDa protein containing 83 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
OPSD00071-5UG - Recombinant MIP-3 beta / CCL19 |
|||
OPSD00071-5UG | Aviva Systems Biology | 5ug | EUR 108 |
OPSD00132-5UG - Recombinant MIP-3 beta / CCL19 |
|||
OPSD00132-5UG | Aviva Systems Biology | 5ug | EUR 108 |
Human MIP-3 beta Recombinant Protein Lyophilized |
|||
IHUMIP3BRLY5UG | Innovative research | each | EUR 341 |
Description: Human MIP-3 beta Recombinant Protein Lyophilized |
Mouse MIP-3 beta Recombinant Protein Lyophilized |
|||
IMSMIP3BRLY5UG | Innovative research | each | EUR 341 |
Description: Mouse MIP-3 beta Recombinant Protein Lyophilized |
Human MIP-3 beta Recombinant Protein Lyophilized |
|||
MBS8432772-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Mouse MIP-3 beta Recombinant Protein Lyophilized |
|||
MBS8434280-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Mouse Anti-Human MIP-3 alpha (beta) |
|||
MBS690310-05mg | MyBiosource | 0.5mg | EUR 525 |
Mouse Anti-Human MIP-3 alpha (beta) |
|||
MBS690310-5x05mg | MyBiosource | 5x0.5mg | EUR 2080 |
Human MIP-3 beta ELISA Kit, pink-ONE |
|||
K0332182P | KOMA BIOTECH | 96well | EUR 299 |
MIP-1 beta, CCL4, rat |
|||
RC355-15 | Bio Basic | 5ug | EUR 125.26 |
Human CCL19/MIP-3 beta PicoKine ELISA Kit |
|||
MBS176518-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 2755 |
Human CCL19/MIP-3 beta PicoKine ELISA Kit |
|||
MBS176518-96StripWells | MyBiosource | 96-Strip-Wells | EUR 600 |
Mouse CCL19/MIP-3 beta PicoKine ELISA Kit |
|||
MBS177585-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 2755 |
Mouse CCL19/MIP-3 beta PicoKine ELISA Kit |
|||
MBS177585-96StripWells | MyBiosource | 96-Strip-Wells | EUR 600 |
OKRC00720-96W - MIP-3 beta ELISA Kit (Human) |
|||
OKRC00720-96W | Aviva Systems Biology | 96Wells | EUR 525 |
OKRC01262-96W - MIP-3 beta ELISA Kit (Mouse) |
|||
OKRC01262-96W | Aviva Systems Biology | 96Wells | EUR 525 |
Human MIP-1 beta (CCL4) |
|||
MBS692135-0002mg | MyBiosource | 0.002mg | EUR 300 |
Human MIP-1 beta (CCL4) |
|||
MBS692135-001mg | MyBiosource | 0.01mg | EUR 450 |
Human MIP-1 beta (CCL4) |
|||
MBS692135-5x001mg | MyBiosource | 5x0.01mg | EUR 1725 |
MIP-1 beta, CCL4, human |
|||
RC314-15 | Bio Basic | 2ug | EUR 121.6 |
Rabbit Anti Human Mip-3 Beta Polyclonal Antibody |
|||
CPBT-65218RH | Creative Diagnostics | 0.1 mg | EUR 659.4 |
Description: Rabbit |
Recombinant Pig MIP-1 Beta |
|||
MBS225413-0005mg | MyBiosource | 0.005mg | EUR 355 |
Recombinant Pig MIP-1 Beta |
|||
MBS225413-5x0005mg | MyBiosource | 5x0.005mg | EUR 1435 |
Human recombinant MIP-1 beta |
|||
MI-300-3 | Austral Biologicals | 10ug | EUR 200 |
Human recombinant MIP-1 beta |
|||
MI-300-4 | Austral Biologicals | 50ug | EUR 800 |
Human recombinant MIP-2 beta |
|||
MI-320-3 | Austral Biologicals | 10ug | EUR 200 |
Human recombinant MIP-2 beta |
|||
MI-320-4 | Austral Biologicals | 50ug | EUR 800 |
rHu MIP-3-beta |
|||
AK8232-0005 | Akron Biotech | 5µg | Ask for price |
rHu MIP-3-beta |
|||
AK8232-0020 | Akron Biotech | 20µg | Ask for price |
rHu MIP-3-beta |
|||
AK8232-0100 | Akron Biotech | 100µg | Ask for price |
rHu MIP-3-beta |
|||
AK8232-1000 | Akron Biotech | 1mg | Ask for price |
MIP-1 beta Recombinant Protein |
|||
40-358-0002mg | ProSci | 0.002 mg | EUR 311.1 |
Description: Both MIP-1 alpha and MIP-1 beta are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1 alpha and MIP-1 beta exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1 alpha selectively attracting CD8+ lymphocytes and MIP-1 beta selectively attracting CD4+ lymphocytes. Additionally, MIP-1 alpha and MIP-1 beta have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1 alpha and MIP-1 beta are active on human and murine hematopoietic cells. Recombinant murine MIP-1 beta is a 7.8 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
MIP-1 beta Recombinant Protein |
|||
40-358-001mg | ProSci | 0.01 mg | EUR 437.1 |
Description: Both MIP-1 alpha and MIP-1 beta are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1 alpha and MIP-1 beta exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1 alpha selectively attracting CD8+ lymphocytes and MIP-1 beta selectively attracting CD4+ lymphocytes. Additionally, MIP-1 alpha and MIP-1 beta have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1 alpha and MIP-1 beta are active on human and murine hematopoietic cells. Recombinant murine MIP-1 beta is a 7.8 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
MIP-1 beta Recombinant Protein |
|||
40-365-0002mg | ProSci | 0.002 mg | EUR 311.1 |
Description: Both MIP-1 alpha and MIP-1 beta are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1 alpha and MIP-1 beta exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1 alpha selectively attracting CD8+ lymphocytes and MIP-1 beta selectively attracting CD4+ lymphocytes. Additionally, MIP-1 alpha and MIP-1 beta have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1 alpha and MIP-1 beta are active on human and murine hematopoietic cells. Recombinant human MIP-1 betais a 7.6 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
MIP-1 beta Recombinant Protein |
|||
40-365-001mg | ProSci | 0.01 mg | EUR 437.1 |
Description: Both MIP-1 alpha and MIP-1 beta are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1 alpha and MIP-1 beta exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1 alpha selectively attracting CD8+ lymphocytes and MIP-1 beta selectively attracting CD4+ lymphocytes. Additionally, MIP-1 alpha and MIP-1 beta have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1 alpha and MIP-1 beta are active on human and murine hematopoietic cells. Recombinant human MIP-1 betais a 7.6 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
MIP-1 beta Recombinant Protein |
|||
40-407-0005mg | ProSci | 0.005 mg | EUR 311.1 |
Description: Both MIP-1 alpha and MIP-1 beta are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1 alpha and MIP-1 beta exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1 alpha selectively attracting CD8+ lymphocytes and MIP-1 beta selectively attracting CD4+ lymphocytes. Additionally, MIP-1 alpha and MIP-1 beta have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1 alpha and MIP-1 beta are active on human and murine hematopoietic cells. Recombinant rat MIP-1 beta is a 7.8 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
MIP-1 beta Recombinant Protein |
|||
40-407-002mg | ProSci | 0.02 mg | EUR 437.1 |
Description: Both MIP-1 alpha and MIP-1 beta are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1 alpha and MIP-1 beta exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1 alpha selectively attracting CD8+ lymphocytes and MIP-1 beta selectively attracting CD4+ lymphocytes. Additionally, MIP-1 alpha and MIP-1 beta have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1 alpha and MIP-1 beta are active on human and murine hematopoietic cells. Recombinant rat MIP-1 beta is a 7.8 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
CXCL2 (Gro beta, MIP-2) |
|||
MBS614445-01mg | MyBiosource | 0.1mg | EUR 840 |
CXCL2 (Gro beta, MIP-2) |
|||
MBS614445-5x01mg | MyBiosource | 5x0.1mg | EUR 3625 |
MIP-3-beta Antibody |
|||
abx235194-100g | Abbexa | 100 µg | EUR 350 |
MIP-3-beta Antibody |
|||
abx235194-100ug | Abbexa | 100 ug | EUR 577.2 |
Anti-CCL19/Mip 3 Beta Rabbit Monoclonal Antibody |
|||
M01605 | BosterBio | 100ug/vial | EUR 154 |
Description: WB 1:500-1:2000 |
Anti-CCL19/Mip 3 Beta Rabbit Monoclonal Antibody |
|||
MBS179703-01mL | MyBiosource | 0.1mL | EUR 450 |
Anti-CCL19/Mip 3 Beta Rabbit Monoclonal Antibody |
|||
MBS179703-5x01mL | MyBiosource | 5x0.1mL | EUR 1870 |
Human CCL19/MIP-3 Beta ELISA Kit PicoKine® |
|||
EK0456 | BosterBio | 96 wells | EUR 499 |
Description: Human CCL19/MIP-3 Beta ELISA Kit PicoKine® (96 Tests). Quantitate Human CCL19 in cell culture supernatants, cell lysates, serum and plasma (heparin, EDTA). Sensitivity: 10pg/ml. |
Mouse CCL19/MIP-3 beta ELISA Kit PicoKine® |
|||
EK0457 | BosterBio | 96 wells | EUR 499 |
Description: Mouse CCL19/MIP-3 beta ELISA Kit PicoKine® (96 Tests). Quantitate Mouse Ccl19 in cell culture supernatants, cell lysates, serum and plasma (heparin, EDTA). Sensitivity: 10pg/ml. |
Human MIP-3 Beta Flow Cytometry Assay - Group 6 |
|||
HX87223 | Antigenix America | 96 Tests | EUR 270 |
Rat Monoclonal anti-mouse CCL-19 (MIP-3 beta) |
|||
mAP-0171 | Angio Proteomie | 100ug | EUR 250 |
Sheep Polyclonal anti-Human CCL-19 (MIP-3 beta) |
|||
hAP-5710 | Angio Proteomie | 50ug | EUR 400 |
Mouse Monoclonal anti-human CCL-19 (MIP-3 beta) |
|||
hAP-0143 | Angio Proteomie | 100ug | EUR 250 |
MIP-1 beta (human) ELISA Kit |
|||
K4785-100 | Biovision | 100 assays | EUR 970.8 |
Description: Sensitive, Colorimetric Assay |
Mouse MIP-1 beta ELISA Kit |
|||
GWB-SKR096 | GenWay Biotech | 96 Tests | Ask for price |
Mouse MIP-1 beta ELISA Kit |
|||
K0331252 | KOMA BIOTECH | 96well | EUR 271 |
Description: https://komabiotech.co.kr/labiskoma/datasheet/K0331252.pdf |
Human MIP-1 beta ELISA Kit |
|||
K0332139 | KOMA BIOTECH | 96well | EUR 271 |
Rabbit anti Pig MIP-1 Beta |
|||
MBS225020-01mg | MyBiosource | 0.1mg | EUR 645 |
Rabbit anti Pig MIP-1 Beta |
|||
MBS225020-5x01mg | MyBiosource | 5x0.1mg | EUR 2730 |
Rabbit anti Pig MIP-1 Beta |
|||
MBS225021-005mg | MyBiosource | 0.05mg | EUR 645 |
Rabbit anti Pig MIP-1 Beta |
|||
MBS225021-5x005mg | MyBiosource | 5x0.05mg | EUR 2730 |
Pig MIP-1 Beta (CCL4) Protein |
|||
abx670310-100g | Abbexa | 100 µg | EUR 312.5 |
Pig MIP-1 Beta (CCL4) Protein |
|||
abx670310-5ug | Abbexa | 5 ug | EUR 493.2 |
RABBIT ANTI HUMAN MIP-1 BETA |
|||
MBS221343-01mg | MyBiosource | 0.1mg | EUR 635 |
RABBIT ANTI HUMAN MIP-1 BETA |
|||
MBS221343-5x01mg | MyBiosource | 5x0.1mg | EUR 2695 |
MIP-1 beta, CCL4, murine (mouse) |
|||
RC335-15 | Bio Basic | 2ug | EUR 125.26 |
Rabbit Anti Human Mip-3 Beta Polyclonal Antibody,Biotin |
|||
CPBT-65217RH | Creative Diagnostics | 50 µg | EUR 659.4 |
Description: Rabbit |
MIP-1 beta Rabbit mAb, capture |
|||
E2RB20113UC | EnoGene | 100ul | EUR 485 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
Anti-Mouse MIP-1 beta Antibody |
|||
103-P79 | ReliaTech | 100 µg | EUR 245.7 |
Description: Both MIP-1α and MIP-1β are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1α and MIP-1β exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1α selectively attracting CD8+ lymphocytes and MIP-1β selectively attracting CD4+ lymphocytes. Additionally, MIP-1α and MIP-1β have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1α and MIP-1β are active on human and murine hematopoietic cells. Recombinant murine MIP-1β is a 7.8 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
Anti-Human MIP-1 beta Antibody |
|||
102-P64 | ReliaTech | 100 µg | EUR 245.7 |
Description: Both MIP-1α and MIP-1β are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1α and MIP-1β exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1α selectively attracting CD8+ lymphocytes and MIP-1β selectively attracting CD4+ lymphocytes. Additionally, MIP-1α and MIP-1β have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1α and MIP-1β are active on human and murine hematopoietic cells. Recombinant human MIP-1βis a 7.6 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines |
Recombinant Human MIP-1 beta/CCL4 |
|||
HECCP-0401 | Cyagen | 10ug | Ask for price |
Human MIP-1 beta (CCL4) Recombinant |
|||
MBS553044-0002mg | MyBiosource | 0.002mg | EUR 165 |
Human MIP-1 beta (CCL4) Recombinant |
|||
MBS553044-001mg | MyBiosource | 0.01mg | EUR 245 |
CXCL2 (Gro beta, MIP-2) (AP) |
|||
MBS6470975-01mL | MyBiosource | 0.1mL | EUR 1115 |
CXCL2 (Gro beta, MIP-2) (AP) |
|||
MBS6470975-5x01mL | MyBiosource | 5x0.1mL | EUR 4875 |
CXCL2 (Gro beta, MIP-2) (PE) |
|||
MBS6470996-01mL | MyBiosource | 0.1mL | EUR 1115 |
CXCL2 (Gro beta, MIP-2) (PE) |
|||
MBS6470996-5x01mL | MyBiosource | 5x0.1mL | EUR 4875 |
Rat MIP-1 beta Recombinant Protein |
|||
R20-035 | ReliaTech | 20 µg | EUR 196.35 |
Description: Both MIP-1α and MIP-1β are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1α and MIP-1β exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1α selectively attracting CD8+ lymphocytes and MIP-1β selectively attracting CD4+ lymphocytes. Additionally, MIP-1α and MIP-1β have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1α and MIP-1β are active on human and murine hematopoietic cells. Recombinant rat MIP-1β is a 7.8 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
Rat MIP-1 beta Recombinant Protein |
|||
R20-035S | ReliaTech | 5 µg | EUR 92.4 |
Description: Both MIP-1α and MIP-1β are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1α and MIP-1β exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1α selectively attracting CD8+ lymphocytes and MIP-1β selectively attracting CD4+ lymphocytes. Additionally, MIP-1α and MIP-1β have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1α and MIP-1β are active on human and murine hematopoietic cells. Recombinant rat MIP-1β is a 7.8 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
Recombinant Human MIP-1 beta (CCL4L1) |
|||
MBS4159822-001mg | MyBiosource | 0.01mg | EUR 230 |
Recombinant Human MIP-1 beta (CCL4L1) |
|||
MBS4159822-01mg | MyBiosource | 0.1mg | EUR 810 |
Recombinant Human MIP-1 beta (CCL4L1) |
|||
MBS4159822-1mg | MyBiosource | 1mg | EUR 3850 |
Recombinant Human MIP-1 beta (CCL4L1) |
|||
MBS4159822-5x1mg | MyBiosource | 5x1mg | EUR 17080 |
Recombinant Human MIP-1 beta (CCL4L1) |
|||
Z102105 | ABM | 10 µg | EUR 85 |
Description: MIP-1-beta is one of the peptides of Macrophage Inflammatory Protein-1 that is produced by macrophages following their stimulation with bacterial endotoxins. MIP-1-beta causes local inflammatory responses, and induces superoxide production by neutrophils. The aforementioned activates of MIP-1-beta are exerted following its binding to CCR5. |
Recombinant Human MIP-1 beta (CCL4L1) |
|||
Z102107 | ABM | 100 µg | EUR 600 |
Description: MIP-1-beta is one of the peptides of Macrophage Inflammatory Protein-1 that is produced by macrophages following their stimulation with bacterial endotoxins. MIP-1-beta causes local inflammatory responses, and induces superoxide production by neutrophils. The aforementioned activates of MIP-1-beta are exerted following its binding to CCR5. |
Recombinant Human MIP-1 beta (CCL4L1) |
|||
Z102109 | ABM | 1.0 mg | EUR 3250 |
Description: MIP-1-beta is one of the peptides of Macrophage Inflammatory Protein-1 that is produced by macrophages following their stimulation with bacterial endotoxins. MIP-1-beta causes local inflammatory responses, and induces superoxide production by neutrophils. The aforementioned activates of MIP-1-beta are exerted following its binding to CCR5. |
CXCL2 (Gro beta, MIP-2) (APC) |
|||
MBS6470976-01mL | MyBiosource | 0.1mL | EUR 1115 |
CXCL2 (Gro beta, MIP-2) (APC) |
|||
MBS6470976-5x01mL | MyBiosource | 5x0.1mL | EUR 4875 |
CXCL2 (Gro beta, MIP-2) (HRP) |
|||
MBS6470990-01mL | MyBiosource | 0.1mL | EUR 1115 |
CXCL2 (Gro beta, MIP-2) (HRP) |
|||
MBS6470990-5x01mL | MyBiosource | 5x0.1mL | EUR 4875 |
Human MIP-1 beta Recombinant Protein |
|||
100-074 | ReliaTech | 10 µg | EUR 196.35 |
Description: Both MIP-1α and MIP-1β are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1α and MIP-1β exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1α selectively attracting CD8+ lymphocytes and MIP-1β selectively attracting CD4+ lymphocytes. Additionally, MIP-1α and MIP-1β have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1α and MIP-1β are active on human and murine hematopoietic cells. Recombinant human MIP-1βis a 7.6 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
Human MIP-1 beta Recombinant Protein |
|||
100-074S | ReliaTech | 2 µg | EUR 92.4 |
Description: Both MIP-1α and MIP-1β are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1α and MIP-1β exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1α selectively attracting CD8+ lymphocytes and MIP-1β selectively attracting CD4+ lymphocytes. Additionally, MIP-1α and MIP-1β have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1α and MIP-1β are active on human and murine hematopoietic cells. Recombinant human MIP-1βis a 7.6 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
Mouse MIP-1 beta Recombinant Protein |
|||
M10-077 | ReliaTech | 10 µg | EUR 196.35 |
Description: Both MIP-1α and MIP-1β are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1α and MIP-1β exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1α selectively attracting CD8+ lymphocytes and MIP-1β selectively attracting CD4+ lymphocytes. Additionally, MIP-1α and MIP-1β have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1α and MIP-1β are active on human and murine hematopoietic cells. Recombinant murine MIP-1β is a 7.8 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
Mouse MIP-1 beta Recombinant Protein |
|||
M10-077S | ReliaTech | 2 µg | EUR 92.4 |
Description: Both MIP-1α and MIP-1β are structurally and functionally related CC chemokines. They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells. While both MIP-1α and MIP-1β exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1α selectively attracting CD8+ lymphocytes and MIP-1β selectively attracting CD4+ lymphocytes. Additionally, MIP-1α and MIP-1β have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells. Both human and murine MIP-1α and MIP-1β are active on human and murine hematopoietic cells. Recombinant murine MIP-1β is a 7.8 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
CXCL2 (Gro beta, MIP-2) (FITC) |
|||
MBS6470978-01mL | MyBiosource | 0.1mL | EUR 1115 |
CXCL2 (Gro beta, MIP-2) (FITC) |
|||
MBS6470978-5x01mL | MyBiosource | 5x0.1mL | EUR 4875 |
Rabbit polyclonal MIP-1 beta antibody |
|||
TA319165 | Origene Technologies GmbH | 100 µg | Ask for price |
Rat GRO Beta/Mip-2 Antibody |
|||
GWB-2FD7C5 | GenWay Biotech | 0.1 mg | Ask for price |
CXCL2 (Gro beta, MIP-2) (Biotin) |
|||
MBS6470977-01mL | MyBiosource | 0.1mL | EUR 1115 |
CXCL2 (Gro beta, MIP-2) (Biotin) |
|||
MBS6470977-5x01mL | MyBiosource | 5x0.1mL | EUR 4875 |
GRO beta / MIP-2 (CXCL2) Protein |
|||
20-abx261590 | Abbexa |
|
|
GRO beta / MIP-2 (CXCL2) Protein |
|||
20-abx261604 | Abbexa |
|
|
Human MIP-1 Beta (CCL4) Flow Cytometry Assay - Group 3 |
|||
HX88521 | Antigenix America | 96 Tests | EUR 210 |
Mouse MIP-3 Beta (CCL19) Flow Cytometry Assay - Group 4 |
|||
MX30222 | Antigenix America | 96 Tests | EUR 270 |
Human CCL19 / MIP-3 beta Protein, Tag Free (HPLC verified) |
|||
CC9-H5215 | ACROBIOSYSTEMS | 50ug | EUR 3150.1 |
Description: Human CCL19, Tag Free (CC9-H5215) is expressed from human 293 cells (HEK293). It contains AA Gly 22 - Ser 98 (Accession # Q99731-1). |
MIP-3-beta/CCL19, Mouse |
|||
HY-P7264 | MedChemExpress | 50ug | EUR 639.6 |
anti- MIP-3-beta antibody |
|||
FNab05194 | FN Test | 100µg | EUR 606.3 |
Description: Antibody raised against MIP-3-beta |
Recombinant Human MIP-3 beta/ CCL19 Protein, GST, E.coli-1mg |
|||
QP8024-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |